Cargando…
SEOM clinical guidelines in early stage breast cancer (2018)
Breast cancer is the most common cancer in women in our country and it is usually diagnosed in the early and potentially curable stages. Nevertheless, around 20–30% of patients will relapse despite appropriate locoregional and systemic therapies. A better knowledge of this disease is improving our a...
Autores principales: | Ayala de la Peña, F., Andrés, R., Garcia-Sáenz, J. A., Manso, L., Margelí, M., Dalmau, E., Pernas, S., Prat, A., Servitja, S., Ciruelos, E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339657/ https://www.ncbi.nlm.nih.gov/pubmed/30443868 http://dx.doi.org/10.1007/s12094-018-1973-6 |
Ejemplares similares
-
SEOM clinical guidelines in early-stage breast cancer 2015
por: Garcia-Saenz, J. A., et al.
Publicado: (2015) -
SEOM-GEICAM-SOLTI clinical guidelines for early-stage breast cancer (2022)
por: Ayala de la Peña, Francisco, et al.
Publicado: (2023) -
SEOM–GEICAM–SOLTI clinical guidelines in advanced breast cancer (2022)
por: Garcia-Saenz, Jose Angel, et al.
Publicado: (2023) -
SEOM clinical guidelines on cardiovascular toxicity (2018)
por: Virizuela, J. A., et al.
Publicado: (2019) -
SEOM clinical practice guideline: management and prevention of febrile neutropenia in adults with solid tumors (2018)
por: Carmona-Bayonas, A., et al.
Publicado: (2018)